BCDA BioCardia Inc.
5,314
$0.41
$0.018
(4.59%)
| Watchers | 5,314 |
| 52-Wk Low | $0.32 |
| 52-Wk High | $2.92 |
| Market Cap | $10.7M |
| Volume | 25,801.00 |
| 52-Wk High | $2.92 |
| 52-Wk Low | $0.32 |
BioCardia Full Year 2023 Earnings: Misses ExpectationsSimply Wall St • about 2 months ago
BioCardia ( NASDAQ:BCDA ) Full Year 2023 Results Key Financial Results Revenue: US$477.0k (down 65% from FY 2022). Net...
Share to Feed
Related Stocks: NAS:BCDA...
SUNNYVALE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- BioCardia , Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia (NASDAQ:BCDA) publiera mercredi 27 mars son dernier rapport de r sultats. D chiffrez le rapport avec l'aide de Benzinga.
D finition de b n fices, r sultat net et BPA
Les b n fices et le BPA...
BioCardia (NASDAQ:BCDA) render noti i prossimi risultati degli utili mercoled 27 marzo. Ecco la guida di Benzinga con tutte le informazioni pi importanti per la pubblicazione degli utili.
Cosa...
El mi rcoles, 27 de marzo, BioCardia (NASDAQ:BCDA) publicar su ltimo informe de ganancias. El avance de Benzinga para BioCardia est incluido en el siguiente informe.
Qu son ganancias, ingresos...
SUNNYVALE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- BioCardia , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia and StemCardia partners for heart failure treatment candidate...
Partnership targets heart failure, the leading cause of death and a condition with limited treatment optionsBioCardia's biotherapeutic delivery system with established safety profile enables...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...